---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-011142"
form_type: "8-K"
ticker: "SYRA"
cik: "0001922335"
company_name: "Syra Health Corp"
filed_at: "2024-03-25T23:59:59+00:00"
generated_at: "2026-06-04T08:47:26.977471+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Syra Health 2023 revenue $5.5M, net loss $2.94M; projects 64-100% growth in 2024

## Summary
- FY2023 revenue $5.5M, net loss $(2.94M), vs $5.6M and $(2.12M) in 2022.
- Gross profit margin improved 670 bps to 25.6% from 18.9% in 2022 on mix shift to higher-margin units.
- Adjusted EBITDA loss widened to $(2.8M) from $(2.1M); cash balance $3.3M with no long-term debt.
- Guides FY2024 revenue of $9-$11M (64-100% growth), excluding potential revenue from recent Caduceus federal contract.

## SEC filing metadata
- accession: 0001493152-24-011142
- form_type: 8-K
- ticker: SYRA
- cik: 0001922335
- company_name: Syra Health Corp
- filed_at: 2024-03-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1922335/000149315224011142/0001493152-24-011142-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1922335/000149315224011142/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-011142
- JSON: https://secwatch.observer/filing/0001493152-24-011142.json
- Plain text: https://secwatch.observer/filing/0001493152-24-011142.txt

## Key facts
- Earnings Releases
  Syra Health Corp reported the fourth quarter and fiscal year ended December 31, 2023 results: revenue $5.5 million, net income $(2.94 million). Guidance reaffirmed.
  - Period: the fourth quarter and fiscal year ended December 31, 2023
  - Revenue: $5.5 million
  - Net income: $(2.94 million)
  - Guidance: reaffirmed
  - Result: reported results
  source text: and technology solutions, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023. 2023 Financial Highlights ● 2023 revenue of $5.5 million compared to $5.6 million in 2022. ● Business units excluding Healthcare Workforce grew 250% and comprised 23% of total revenues in 2023, versus only 6% in 2022. ● Population
  evidence_url: https://www.sec.gov/Archives/edgar/data/1922335/000149315224011142/0001493152-24-011142-index.htm
- Earnings Releases
  Syra Health Corp reported full-year 2024 results: revenue $9 to $11 million. Guidance initiated.
  - Period: full-year 2024
  - Revenue: $9 to $11 million
  - Guidance: initiated
  - Result: guidance update
  source text: The Company expects full-year 2024 revenue of $9 to $11 million, representing a growth of 64%-100% versus 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1922335/000149315224011142/0001493152-24-011142-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.